Literature DB >> 27887801

Cardio-cerebrovascular disease and Helicobacter pylori-related metabolic syndrome: We consider eradication therapy as a potential cardio-cerebrovascular prevention strategy.

Jannis Kountouras1, Stergios A Polyzos2, Panagiotis Katsinelos2, Christos Zeglinas2, Fotini Artemaki2, Dimitri Tzivras2, Elizabeth Vardaka2, Emmanouel Gavalas2, Iordanis Romiopoulos2, Constantina Simeonidou2, Nikolaos Grigoriadis2, Constantinos Kountouras2, Efthimios Dardiotis2, Georgia Deretzi2.   

Abstract

Entities:  

Keywords:  Cardiovascular disease; Eradication therapy; Fibrinogen; Helicobacter pylori; Metabolic syndrome

Mesh：

Substances：

Year:  2016        PMID： 27887801     DOI： 10.1016/j.ijcard.2016.11.265

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  7 in total

1.  Current Helicobacter pylori infection is significantly associated with subclinical coronary atherosclerosis in healthy subjects: A cross-sectional study.

Authors:  Minyoung Lee; Haeri Baek; Jong Suk Park; Sohee Kim; Chanhee Kyung; Su Jung Baik; Byoung Kwon Lee; Jie-Hyun Kim; Chul Woo Ahn; Kyung Rae Kim; Shinae Kang
Journal:  PLoS One       Date:  2018-03-02       Impact factor: 3.240

2.  Hellenic consensus on Helicobacter pylori infection.

Authors:  Sotirios D Georgopoulos; Spyridon Michopoulos; Theodoros Rokkas; Pericles Apostolopoulos; Evangelos Giamarellos; Dimitrios Kamberoglou; Andreas Mentis; Konstantinos Triantafyllou
Journal:  Ann Gastroenterol       Date:  2020-01-07

3.  Impact of Helicobacter pylori-related Metabolic Syndrome and Gastroesophageal Reflux Disease on the Risk of Acute Myocardial Infarction.

Authors:  Jannis Kountouras; Apostolis Papaefthymiou; Michael Doulberis; Stergios A Polyzos; Christos Zavos; Evangelos Kazakos; Sofia K Tzika; Elisabeth Vardaka; Christos Liatsos; Panagiotis Katsinelos
Journal:  J Neurogastroenterol Motil       Date:  2021-01-30       Impact factor: 4.924

4.  Helicobacter pylori infection affects the human gastric microbiome, as revealed by metagenomic sequencing.

Authors:  Daoming Wang; Tongda Zhang; Yueqi Lu; Changzheng Wang; Yumei Wu; Jiandong Li; Ye Tao; Le Deng; Xiaoyin Zhang; Jinmin Ma
Journal:  FEBS Open Bio       Date:  2022-03-25       Impact factor: 2.792

5.  Impact of Active Helicobacter pylori Infection-related Metabolic Syndrome on Systemic Arterial Hypertension.

Authors:  Jannis Kountouras; Apostolis Papaefthymiou; Stergios A Polyzos; Evangelos Kazakos; Elisabeth Vardaka; Maria Touloumtzi; Maria Tzitiridou-Chatzopoulou; Christos Liatsos; Ioanna-Konstantina Sgantzou; Jürg Knuchel; Michael Doulberis
Journal:  Arq Bras Cardiol       Date:  2022-09       Impact factor: 2.667

Review 6.  Helicobacter pylori infection and esophageal adenocarcinoma: a review and a personal view.

Authors:  Stergios A Polyzos; Christos Zeglinas; Fotini Artemaki; Michael Doulberis; Evangelos Kazakos; Panagiotis Katsinelos; Jannis Kountouras
Journal:  Ann Gastroenterol       Date:  2017-11-16

7.  Helicobacter pylori-Related Metabolic Parameters and Premalignant Gastric Mucosa Histological Lesions in Swiss Bariatric Patients.

Authors:  Michael Doulberis; Noah Thierry Pierre; Giulia Manzini; Apostolis Papaefthymiou; Jannis Kountouras; Jolanta Klukowska-Rötzler; Stergios A Polyzos; Simone Srivastava; Aristomenis K Exadaktylos; Jürg Knuchel; Thomas Kuntzen; David S Srivastava
Journal:  Microorganisms       Date:  2021-06-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.